RDMD is a healthcare technology company dedicated to accelerating treatments for patients with rare diseases. RDMD has developed a technology platform that generates deep data insights to accelerate rare disease research and drug development, as well as a patient application that empowers patients and families to get access to and benefit from their own medical data. RDMD was founded in 2017 by technology developer Onno Faber, following his diagnosis and journey with the rare disease neurofibromatosis type 2.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/21/18 | $3,000,000 | Seed |
First Round Capital Garuda Lux Capital  Shasta Ventures | undisclosed |
| 04/16/20 | $14,000,000 | Series A |
Garuda Lux Capital Maveron Spark Capital Village Global | undisclosed |
